$147.94+$3.04 (+2.10%)as of market close, Jul 24, 2026
EMR — Emerson Electric Company stock price, chart and key statistics
Key stats
Price data
- Price
- $147.94
- Change YTD
- +8.92%
- Next earnings
- Aug 4, 2026 · After close
- Market cap
- 82.9B
- Enterprise value
- 88.6B
- Shares outstanding
- 560.1M
- 52W low
- $122.64
- 52W high
- $165.15
- From 52W high
- -10.42%
- From 52W low
- +20.63%
- 52W range
- 60%
- Beta
- 1.24
Volume
- Rel volume
- 1.81×
- 30D volume
- 2.7M
- 30D $ vol
- 385.8M
Fundamentals
- Sales (ttm)
- 18.3B
- Sales/share
- $32.70
- EPS (ttm)
- $4.34
- FCF (ttm)
- 3.1B
- FCF/share
- $5.56
- Book value/share
- $36.25
- Net margin
- 13.35%
- ROE
- 12.05%
- ROA
- 5.81%
- Debt / equity
- 0.37×
- Current ratio
- 0.87
Growth (CAGR, ttm) · 10Y
- Sales
- +1.88%
- Net income
- +2.40%
- FCF
- +2.78%
- Shares
- -1.38%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +4.05%
- Sales/share
- +3.30%
- FCF/share
- +4.22%
- Book value/share
- +11.73%
- Dividend/share
- +1.37%
- Price
- +10.24%
- Total return
- +13.00%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 33.9×
- Fwd P/E
- 20.0×
- P/S (ttm)
- 4.5×
- P/B (mrq)
- 4.1×
- P/FCF (ttm)
- 26.6×
- EV/Sales (ttm)
- 4.8×
- FCF yield (ttm)
- 3.76%
- Dividend yield (fwd)
- 1.50%
- Dividend/share (fwd)
- $2.22
- Buyback yield (ttm)
- 0.71%
- Shareholder yield (ttm)
- 2.18%
Vs own 10Y history
- P/E
- 94th
- P/S
- 96th
- P/B
- 31st
- P/FCF
- 78th
Bar = where today's multiple sits in EMR's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
+2.10%
1W
+6.02%
1M
+4.60%
3M
+3.86%
YTD
+8.92%
1Y
+0.72%
5Y
+52.11%
Financial statements
Open full EMR financials →Related Technology
1MEmerson Electric Company (EMR) trades at $147.94 with a live price and an interactive chart covering 54+ years of daily price history, plus key valuation metrics. ChartRow also publishes EMR's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full EMR financial statements →
